North China Pharmaceutical Company Ltd.
SSE:600812.SS
6.08 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 9,869.576 | 10,120.201 | 10,499.947 | 10,384.575 | 11,492.504 | 10,880.768 | 9,213.775 | 7,709.122 | 8,082.463 | 7,902.502 | 9,400.973 | 12,438.144 | 11,125.706 | 12,136.746 | 10,286.643 | 4,882.522 | 4,910.957 | 4,240.587 | 3,598.124 | 3,971.939 | 4,124.21 | 3,591.392 | 3,003.474 | 2,837.306 | 1,667.889 | 1,630.338 | 1,152.676 | 1,464.034 | 1,567.739 | 1,402.732 | 1,149.041 | 904.008 |
| Cost of Revenue
| 6,714.659 | 6,906.991 | 6,995.026 | 6,702.616 | 7,306.846 | 6,287.856 | 5,326.661 | 5,265.154 | 6,517.822 | 6,464.857 | 7,876.912 | 11,162.228 | 10,053.083 | 11,132.79 | 8,764.078 | 3,388.19 | 3,248.548 | 3,032.373 | 2,885.012 | 3,227.442 | 3,417.861 | 2,572.826 | 2,163.02 | 2,074.717 | 1,313.647 | 1,363.763 | 914.533 | 1,092.342 | 1,157.452 | 1,031.544 | 0 | 588.248 |
| Gross Profit
| 3,154.917 | 3,213.211 | 3,504.921 | 3,681.96 | 4,185.658 | 4,592.912 | 3,887.114 | 2,443.968 | 1,564.641 | 1,437.645 | 1,524.061 | 1,275.916 | 1,072.623 | 1,003.956 | 1,522.565 | 1,494.332 | 1,662.409 | 1,208.214 | 713.113 | 744.498 | 706.349 | 1,018.566 | 840.454 | 762.588 | 354.242 | 266.575 | 238.143 | 371.692 | 410.287 | 371.189 | 1,149.041 | 315.76 |
| Gross Profit Ratio
| 0.32 | 0.318 | 0.334 | 0.355 | 0.364 | 0.422 | 0.422 | 0.317 | 0.194 | 0.182 | 0.162 | 0.103 | 0.096 | 0.083 | 0.148 | 0.306 | 0.339 | 0.285 | 0.198 | 0.187 | 0.171 | 0.284 | 0.28 | 0.269 | 0.212 | 0.164 | 0.207 | 0.254 | 0.262 | 0.265 | 1 | 0.349 |
| Reseach & Development Expenses
| 337.275 | 297.2 | 217.301 | 153.088 | 136.158 | 67.008 | 71.881 | 47.448 | 59.41 | 72.963 | 57.451 | 42.888 | 46.247 | 53.339 | 49.565 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 233.343 | 267.38 | 242.414 | 296.263 | 167.767 | 172.489 | 172.647 | 139.486 | 149.751 | 75.798 | 101.823 | 106.087 | 195.26 | 200.537 | 239.576 | 680.296 | 551.168 | 438.606 | 306.817 | 426.272 | 329.079 | 410.7 | 334.447 | 286.73 | 140.164 | 113.835 | 90.217 | 76.414 | 114.79 | 100.221 | 0 | 55.123 |
| Selling & Marketing Expenses
| 1,138.973 | 1,376.218 | 1,844.069 | 2,161.314 | 2,764.148 | 3,198.557 | 2,639.385 | 1,370.658 | 759.226 | 710.436 | 758.414 | 630.679 | 516.802 | 492.115 | 372.585 | 299.613 | 275.543 | 291.416 | 233.397 | 274.791 | 121.973 | 115.631 | 70.774 | 47.213 | 20.572 | 16.606 | 11.602 | 18.23 | 19.717 | 12.751 | 0 | 9.521 |
| SG&A
| 1,372.316 | 2,278.335 | 2,086.483 | 2,457.577 | 2,931.915 | 3,371.046 | 2,812.032 | 1,510.143 | 908.977 | 786.234 | 860.237 | 736.766 | 712.062 | 692.652 | 612.161 | 979.909 | 826.71 | 730.021 | 540.214 | 701.063 | 451.052 | 526.33 | 405.221 | 333.943 | 160.735 | 130.441 | 101.819 | 94.644 | 134.507 | 112.972 | 0 | 64.644 |
| Other Expenses
| 1,133.644 | 481.221 | 422.795 | 395.841 | 331.175 | 404.872 | -6.473 | -44.42 | 114.765 | 63.344 | 78.25 | 138.993 | 292.571 | 530.211 | 89.794 | 40.834 | 3.715 | 2.328 | 72.821 | 16.49 | 25.641 | 4.555 | -2.923 | -2.595 | -90.155 | 32.536 | 26.474 | 28.421 | 32.61 | 13.69 | -2.615 | -11.897 |
| Operating Expenses
| 2,843.236 | 3,056.757 | 2,726.578 | 3,006.506 | 3,399.248 | 3,842.926 | 3,206.605 | 1,914.004 | 1,325.75 | 1,182.802 | 1,262.712 | 1,152.937 | 1,198.805 | 1,165.316 | 1,053.564 | 999.948 | 846.748 | 748.348 | 555.592 | 713.934 | 460.984 | 537.179 | 416.439 | 343.979 | 170.248 | 138.174 | 107.34 | 103.341 | 146.148 | 122.711 | -2.615 | 130.23 |
| Operating Income
| 311.681 | 156.453 | 872.748 | 779.669 | 810.158 | 803.963 | 204.857 | 103.972 | -35.747 | 10.09 | -22.884 | -115.166 | -263.486 | -381.84 | 277.047 | -320.841 | 408.847 | 148.892 | -24.026 | -195.527 | 110.563 | 336.276 | 252.881 | 237.833 | 152.689 | 134.168 | 132.307 | 227.416 | 228.836 | 273.036 | 246.041 | 173.427 |
| Operating Income Ratio
| 0.032 | 0.015 | 0.083 | 0.075 | 0.07 | 0.074 | 0.022 | 0.013 | -0.004 | 0.001 | -0.002 | -0.009 | -0.024 | -0.031 | 0.027 | -0.066 | 0.083 | 0.035 | -0.007 | -0.049 | 0.027 | 0.094 | 0.084 | 0.084 | 0.092 | 0.082 | 0.115 | 0.155 | 0.146 | 0.195 | 0.214 | 0.192 |
| Total Other Income Expenses Net
| -1.849 | 2.082 | -1,437.822 | -644.764 | -644.864 | -577.088 | -6.473 | -44.42 | 92.192 | 63.121 | -186.669 | 138.967 | 288.568 | 485.923 | -85.62 | -213.71 | -313.286 | -301.79 | 28.654 | -220.42 | -139.152 | -7.714 | -8.347 | -38 | -12.817 | 2.166 | 0.141 | -0.691 | 6.778 | -1.834 | -2.615 | -13.083 |
| Income Before Tax
| 309.833 | 158.536 | -565.074 | 134.905 | 186.68 | 236.902 | 198.384 | 59.552 | 78.145 | 73.212 | 55.221 | 23.801 | 25.082 | 148.113 | 362.141 | -282.041 | 408.137 | 144.262 | 22.901 | -194.237 | 104.987 | 328.562 | 246.89 | 227.968 | 148.274 | 136.334 | 135.372 | 221.688 | 235.614 | 271.203 | 243.426 | 160.344 |
| Income Before Tax Ratio
| 0.031 | 0.016 | -0.054 | 0.013 | 0.016 | 0.022 | 0.022 | 0.008 | 0.01 | 0.009 | 0.006 | 0.002 | 0.002 | 0.012 | 0.035 | -0.058 | 0.083 | 0.034 | 0.006 | -0.049 | 0.025 | 0.091 | 0.082 | 0.08 | 0.089 | 0.084 | 0.117 | 0.151 | 0.15 | 0.193 | 0.212 | 0.177 |
| Income Tax Expense
| 94.866 | 109.148 | 113.707 | 99.523 | 82.203 | 89.001 | 52.567 | 45.114 | 26.514 | 22.361 | 23.429 | 14.308 | 11.021 | 8.15 | 100.336 | 113.882 | 134.188 | 70.153 | 6.585 | 25.749 | 32.175 | 50.692 | 64.374 | 31.127 | 13.032 | 15.838 | 15.474 | 25.797 | 27.255 | 30.071 | 35.876 | -13.288 |
| Net Income
| 126.992 | 4.89 | -678.782 | 35.382 | 97.324 | 153.445 | 150.646 | 18.76 | 54.415 | 62.848 | 41.618 | 13.655 | 17.797 | 124.77 | 241.831 | -382.276 | 269.101 | 60.54 | 38.943 | -187.642 | 59.147 | 213.693 | 130.917 | 139.786 | 111.182 | 105.425 | 112.28 | 187.287 | 205.767 | 238.14 | 207.55 | 160.344 |
| Net Income Ratio
| 0.013 | 0 | -0.065 | 0.003 | 0.008 | 0.014 | 0.016 | 0.002 | 0.007 | 0.008 | 0.004 | 0.001 | 0.002 | 0.01 | 0.024 | -0.078 | 0.055 | 0.014 | 0.011 | -0.047 | 0.014 | 0.06 | 0.044 | 0.049 | 0.067 | 0.065 | 0.097 | 0.128 | 0.131 | 0.17 | 0.181 | 0.177 |
| EPS
| 0.074 | 0.003 | -0.4 | 0.021 | 0.06 | 0.11 | 0.092 | 0.012 | 0.033 | 0.039 | 0.025 | 0.01 | 0.016 | 0.14 | 0.24 | -0.37 | 0.27 | 0.059 | -0.012 | -0.18 | 0.049 | 0.12 | 0.071 | 0.061 | 0.053 | 0.057 | 0.064 | 0.12 | 0.15 | 0.18 | 0.17 | 0.16 |
| EPS Diluted
| 0.074 | 0.003 | -0.4 | 0.021 | 0.06 | 0.11 | 0.092 | 0.012 | 0.033 | 0.039 | 0.025 | 0.01 | 0.016 | 0.14 | 0.24 | -0.37 | 0.27 | 0.059 | -0.012 | -0.18 | 0.049 | 0.12 | 0.071 | 0.061 | 0.053 | 0.057 | 0.064 | 0.12 | 0.15 | 0.18 | 0.17 | 0.16 |
| EBITDA
| 1,631.93 | 1,538.477 | 796.955 | 1,480.829 | 1,378.822 | 1,377.302 | 1,166.236 | 877.004 | 787.888 | 742.657 | 750.754 | 571.212 | 497.9 | 603.206 | 844.596 | 225.871 | 1,091.734 | 663.013 | 515.564 | 279.848 | 324.752 | 717.635 | 637.487 | 572.933 | 225.664 | 266.779 | 233.322 | 268.351 | 264.139 | 248.477 | 1,149.041 | 185.53 |
| EBITDA Ratio
| 0.165 | 0.152 | 0.076 | 0.143 | 0.12 | 0.127 | 0.127 | 0.114 | 0.097 | 0.094 | 0.08 | 0.046 | 0.045 | 0.05 | 0.082 | 0.046 | 0.222 | 0.156 | 0.143 | 0.07 | 0.079 | 0.2 | 0.212 | 0.202 | 0.135 | 0.164 | 0.202 | 0.183 | 0.168 | 0.177 | 1 | 0.205 |